<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM UROLOGIX FDS
FOR QUARTER ENDED 12/31/97 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
       
                             
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JUN-30-1998
<PERIOD-START>                             JUL-01-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                         561,443
<SECURITIES>                                49,819,248
<RECEIVABLES>                                3,784,048
<ALLOWANCES>                                         0
<INVENTORY>                                  3,819,453
<CURRENT-ASSETS>                               444,778
<PP&E>                                       3,355,297
<DEPRECIATION>                               1,211,006
<TOTAL-ASSETS>                              63,729,166
<CURRENT-LIABILITIES>                        3,567,648
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       110,710
<OTHER-SE>                                  60,022,918
<TOTAL-LIABILITY-AND-EQUITY>                63,729,166
<SALES>                                      3,203,845
<TOTAL-REVENUES>                             3,203,845
<CGS>                                        2,140,126
<TOTAL-COSTS>                                2,140,126
<OTHER-EXPENSES>                             3,596,307
<LOSS-PROVISION>                             2,532,588
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (2,140,307)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (2,140,307)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (2,140,307)
<EPS-PRIMARY>                                   (0.21)
<EPS-DILUTED>                                   (0.21)